Bonlutin

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

natural fish oil, Quantity: 600 mg (Equivalent: eicosapentaenoic acid, Qty 90 mg; Equivalent: docosahexaenoic acid, Qty 60 mg); glucosamine sulfate potassium chloride, Quantity: 500 mg (Equivalent: glucosamine, Qty 296 mg; Equivalent: potassium chloride, Qty 123 mg); shark sodium chondroitin sulfate, Quantity: 12.33 mg (Equivalent: chondroitin sulfate, Qty 10 mg)

から入手可能:

Pharmametics Products A Division of Max Biocare Pty Ltd

医薬品形態:

Capsule, soft

構図:

Excipient Ingredients: Gelatin; iron oxide red; d-alpha-tocopherol; hydrogenated vegetable oil; iron oxide black; lecithin; yellow beeswax; purified water; Soya Oil; glycerol; titanium dioxide; propylene glycol; ethyl acetate; ethanol; isopropyl alcohol; strong ammonia solution; polyvinyl acetate phthalate; macrogol 400

投与経路:

Oral

適応症:

Antioxidant/Reduce free radicals formed in the body ; Anti-inflammatory/relieve inflammation ; Decrease/reduce/relieve mild joint aches and pains ; Decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; Helps maintain/supports healthy joint cartilage growth/development/production ; Helps enhance/promote healthy joint function ; Helps enhance/promote joint health ; Maintain/support joint health ; Decrease/reduce/relieve mild joint inflammation/swelling ; Maintain/support joint mobility/flexibility ; Decrease/reduce/relieve mild joint pain/soreness ; Decrease/reduce/relieve mild joint stiffness

製品概要:

Visual Identification: ;

認証ステータス:

Listed

承認日:

2019-08-05